Alvotech revenue breakdown overview

Alvotech revenue for the last year amounted to 492.00 M USD, the most of which — 489.68 M USD — came from its highest performing source at the moment, Biosimilar Medicines, the year earlier bringing 91.43 M USD. The greatest contribution to the revenue figure was made by United States — last year it brought Alvotech 273.04 M USD.